The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety ...

The U.S. health insurance industry — a $1.29 trillion giant — is under strain. Soaring healthcare costs, policy shake-ups, and long-standing access gaps are squeezing not just insurers, but ...